Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

High Levels of Protein p62 Predict Liver Cancer Recurrence

May 18, 2016 11:49 am | News | Comments

Researchers at University of California San Diego School of Medicine and Sanford Burnham Prebys Medical Discovery Institute have discovered that high levels of the protein p62 in human liver samples are strongly associated with cancer recurrence and reduced patient survival. 


AstraZeneca’s Lynparza Fails in Gastric Cancer Phase 3 Trial

May 18, 2016 9:35 am | by Stephanie Guzowski, Editor | News | Comments

AstraZeneca announced Wednesday that its recently approved ovarian cancer treatment Lynparza (olaparib) missed a primary endpoint of improving overall survival in patients with advanced gastric cancer.


Cellular Immunotherapies Represent Long-Term Opportunity in Immuno-Oncology Space

May 18, 2016 9:00 am | by Dan Roberts, Ph.D., Senior Oncology & Hematology Analyst, GlobalData | Articles | Comments

Early studies of these drugs have demonstrated very impressive remission rates of up to 90 percent.


Valeant Announces Expanded Discounts for Nitropress, Isuprel

May 18, 2016 8:59 am | News | Comments

The company will make available to all hospitals in the U.S. an enhanced rebate program to reduce the price of both heart drugs.


Colombia Battles World's Biggest Drugmaker Over Cancer Drug

May 18, 2016 8:39 am | by Joshua Goodman and Linda A. Johnson, Associated Press | News | Comments

Colombia's government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals.


FT Summit Hosts Heated Debate on Drug Pricing

May 18, 2016 8:22 am | by Ryan Bushey, Digital Editor | Articles | Comments

All participants presented intriguing viewpoints for this controversial topic. 


Biogen, UPenn to Collaborate on Multiple Gene Therapy Programs

May 18, 2016 8:10 am | News | Comments

The expansive research and translational development collaboration has multiple objectives, but will primarily focus on the development of therapeutic approaches that target the eye, skeletal muscle and the central nervous system (CNS)


Novartis Separates Drug Business into Pharmaceuticals, Oncology Divisions

May 18, 2016 8:00 am | News | Comments

The new structure reflects the importance of oncology to Novartis following the successful integration of the oncology assets acquired from GSK.


Study Advances Understanding of Colon Cancer and Colitis

May 18, 2016 7:45 am | by University of California Riverside | News | Comments

Inflammatory bowel disease (IBD), of which Crohn’s disease and ulcerative colitis are the main types, is on the increase in the United States. 


Novel Nicotine Inhaler Doubles Smoking Quit Rates

May 18, 2016 7:30 am | by University of Otago | News | Comments

The researchers are currently looking at how to make the inhaler available to all smokers who would like to use it.


UN: Zika Increasingly Alarming But Rio Olympics Should Be OK

May 17, 2016 1:00 pm | by The Associated Press | News | Comments

The World Health Organization's chief says the agency is increasingly worried about the Zika virus.


Wal-Mart Pairs with McKesson to Buy Generic Drugs More Cheaply

May 17, 2016 10:28 am | by Michelle Cortez and Shannon Pettypiece, Bloomberg Business | News | Comments

Wal-Mart Stores Inc., the world’s biggest retailer, is joining forces with McKesson Corp., the largest U.S. pharmaceutical distributor, to purchase generic drugs.


E.Coli 'Anchors' Provide Novel Way to Hijack Superbugs

May 17, 2016 9:44 am | by Monash University | News | Comments

Australian scientists may have found a way to stop deadly bacteria from infecting patients. 


Caribou Biosciences Raises $30M to Continue Gene Editing Research

May 17, 2016 9:43 am | News | Comments

The financing included the participation of new investors.


AstraZeneca Announces Positive Phase 3 Results for Benralizumab

May 17, 2016 9:42 am | News | Comments

The antibody demonstrated significant reductions in the annual asthma exacerbation rate compared to placebo.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.